1 |
Rosenson RS, Brown AS. Statin use in acute coronary syndromes: cellular mechanisms and clinical evidence. Curr Opin Lipidol 2002;13:625-630
DOI
ScienceOn
|
2 |
Shinozaki K, Kashiwagi A, Masada M, Okamura T. Molecular mechanisms of impaired endothelial function associated with insulin resistance. Curr Drug Targets Cardiovasc Haematol Disord 2004;4:1-11
|
3 |
김대중. 마른비만의 치료. 대학비만학회 춘계학술대회 연수강좌 2004;499-503
|
4 |
Chung S. et al., 8. Korean and Caucasian overweight premenopausal women have different relationship of body mass index to percent body fat with age. J Appl Physiol. 2005;99(1):103-107
DOI
ScienceOn
|
5 |
Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214
DOI
ScienceOn
|
6 |
Haffner SM. Abdominal adiposity and cardiometabolic risk: Do we have all the answers? Am J Med. 2007;120(Suppl1):S10-S16
|
7 |
Katsuki A et al., 8. Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Endocr J 2005;52:253-257
DOI
ScienceOn
|
8 |
Lemieux I. et al., 5. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-967
DOI
ScienceOn
|
9 |
Meigs JB. et al., 6. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91:2906-2912
DOI
ScienceOn
|
10 |
Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818
DOI
ScienceOn
|
11 |
Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal weight(MONW) subjects. Appl Physiol Nutr Metab. 2007;32:4-12
DOI
ScienceOn
|
12 |
Ruderman N, Chrisholm D, Pi-Sunyer X, Schneider SH. The metabolically obese, normal-weight individual revisited. Diabetes 1998;47:6699-6713
|
13 |
Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A and Poehlman ET. Metabolic and behavioral characteristics of metabolically obese but norma-weight women. J Clin Endocrionol Metab. 2004;89:5013-5020
DOI
ScienceOn
|
14 |
Sowers JR. Endocrine functions of adipose tissue: focus on adiponectin. Clin Cornerstone 2008;9(1):32-40
DOI
ScienceOn
|
15 |
Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab. 1987;64(6):1169-1173
DOI
|
16 |
Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003;115(Suppl8A):37S-41S
|
17 |
Fu Y, Luo N, Klein RL, Garvey WT. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res. 2005;46(7):1369-1379
DOI
ScienceOn
|
18 |
Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006;83:461S-465S
|
19 |
Katsuki A. et al., 10 Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 2003;26:2341-2344
DOI
ScienceOn
|
20 |
Ruderman NB, Schneider SH, Berchtold P. The "metabolicallyobese", normal-weight induvidual. Am J Clin Nutr 1981;34:1617-1621
|
21 |
Homma Y. Predictors of atherosclerosis. J Atheroscler Thromb 2004;11:265-270
DOI
ScienceOn
|
22 |
Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998;22(12):1145-1158
DOI
ScienceOn
|
23 |
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-949
DOI
ScienceOn
|
24 |
Karelis AD. et al., 7. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90(7):4145-4150
DOI
ScienceOn
|
25 |
Katsuki A. et al., 7. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal weight men. Diabetes Care 2004;27:631-632
DOI
ScienceOn
|
26 |
보건복지부. 2007 건강투자 전략을 위한 건강정책관 핵심지표. 서울: 보건복지부, 2007
|
27 |
Pedersen. et al., 5. Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 2001;7:18-31
|
28 |
Rokling-Andersen MH. et al., 7. Effects of long-term exercise and diet intervention on plasma adipokine concentations. Am J Clin Nutr 2007;86:1293-1301
|
29 |
Molero-Conejo E et al., 7. Lean adolescents with increased risk for metabolic syndrome. Arch Latinoam Nutr 2003;53:39-43
|
30 |
St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans. New definition of the of the metabolly obese, normal-weight individual. Diabetes Care 2004;27:2222-2228
DOI
ScienceOn
|
31 |
Katsuki A. et al., 9. Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 2003;26:2964-2965
DOI
ScienceOn
|
32 |
Puglish MJ, Fernandez ML. Modulation of C-reactive protein, tumor necrosis factor-a, and adiponectin by diet, exercise, and weight loss. J Nutrition 2008;138:2293-2296
DOI
ScienceOn
|